Form DRS - Draft Registration Statement:
SEC Accession No. 0001213900-23-098831
Filing Date
2023-12-27
Accepted
2023-12-27 15:15:59
Documents
8

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 4015493
2 GRAPHIC tanbio_logo.jpg GRAPHIC 53835
3 GRAPHIC tflowchart_001.jpg GRAPHIC 363865
4 GRAPHIC timage_002.jpg GRAPHIC 17105
5 GRAPHIC timage_005.jpg GRAPHIC 411207
6 GRAPHIC timage_006.jpg GRAPHIC 626201
7 GRAPHIC timage_007.jpg GRAPHIC 17129
8 GRAPHIC timage_008.jpg GRAPHIC 22850
  Complete submission text file 0001213900-23-098831.txt   6100369
Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308
Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281
Anbio Biotechnology (Filer) CIK: 0001982708 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07031 | Film No.: 231517689
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)